My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about DNDN

Download image

VANCOUVER, British Columbia, Feb. 14, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued critical insider trading news on Dendreon Corporation (NASDAQ: DNDN).

(Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO )

Dendreon (NASDAQ: DNDN) share prices exhibited impressive relative strength with a 2.9% gain on Monday, Feb 13. The stock still exhibits strong accumulation on up days with heavy volume and selling on light volume. Insiders like CEO, CFO, and other senior officers of Dendreon may have different views on the future prospective of the company business.  The company insiders have sold over 14 million worth of stocks in the past 12 months. A few BIG insider trades were pretty significant like the SVP, Chief Scientific Officer; Urdal David sold 4 million worth of stocks at a price range of $9.65-41.78 USD.  The EVP, General Counsel Secretary Hamm Richard F Jr sold 2.3 million worth of stocks at $39 USD.  While Dendreon share price is near its 6-month high, investor should find out why the company insiders are selling their shares now.

Read Full Insider Trade Report for (NASDAQ: DNDN):
http://www.insiderslab.com/PR3/021412B/DNDN/Dendreon.pdf
(You may need to copy and paste the full link to your browser)

Are Insiders in Drug Industry buying or selling?
The Insiders buy sell ratio in drug industry dropped from 41% to 22% in the past 4 weeks which indicated senior officers, directors, and 5% shareholders in companies of drug industry are selling their shares now.  Among all companies with net insider selling activities, the top 3 companies with most insider net selling in the past 4 weeks are: Amgen Inc. recorded over 75 million net sale by dollar amount, Synageva Biopharma Corp recorded over 32 million net sale by dollar amount, and Johnson & Johnson recorded over 30 million net sale by dollar amount. One thing in common, all the top 3 companies in drug industry with net insider selling are trading at their 6-month high. Insiders like CEO, CFO, and Directors have access to information that others don't, but insiders must report their trades to SEC after they buy/sell BIG.  This gives investors a new source of information before they make their trades.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit http://www.insiderslab.com/disclaimers/disclaimers.php for details.

SOURCE Insiderslab.com; Insiders.hk

RELATED LINKS
http://www.insiderslab.com/indexPR.php
http://www.insiderslab.com/disclaimers/disclaimers.php